146 related articles for article (PubMed ID: 23466604)
21. Pharmacological, neurochemical, and behavioral profile of JB-788, a new 5-HT1A agonist.
Picard M; Morisset S; Cloix JF; Bizot JC; Guerin M; Beneteau V; Guillaumet G; Hevor TK
Neuroscience; 2010 Sep; 169(3):1337-46. PubMed ID: 20580787
[TBL] [Abstract][Full Text] [Related]
22. In vitro assessment of the agonist properties of the novel 5-HT1A receptor ligand, CUMI-101 (MMP), in rat brain tissue.
Hendry N; Christie I; Rabiner EA; Laruelle M; Watson J
Nucl Med Biol; 2011 Feb; 38(2):273-7. PubMed ID: 21315283
[TBL] [Abstract][Full Text] [Related]
23. Benzimidazole derivatives. Part 5: design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT1A/5-HT3 ligands.
López-Rodríguez ML; Benhamú B; Morcillo MJ; Tejada I; Avila D; Marco I; Schiapparelli L; Frechilla D; Del Río J
Bioorg Med Chem; 2004 Oct; 12(19):5181-91. PubMed ID: 15351401
[TBL] [Abstract][Full Text] [Related]
24. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and structural investigation of some pyrimido[5,4-c]quinolin-4(3H)-one derivatives with a long-chain arylpiperazine moiety as potent 5-HT(1A/2A) and 5-HT(7) receptor ligands.
Lewgowd W; Bojarski AJ; Szczesio M; Olczak A; Glowka ML; Mordalski S; Stanczak A
Eur J Med Chem; 2011 Aug; 46(8):3348-61. PubMed ID: 21601317
[TBL] [Abstract][Full Text] [Related]
26. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Niso M; Perrone R; Tortorella V
J Med Chem; 2004 Dec; 47(26):6616-24. PubMed ID: 15588097
[TBL] [Abstract][Full Text] [Related]
27. Structure-activity relationships and molecular modeling studies of novel arylpiperazinylalkyl 2-benzoxazolones and 2-benzothiazolones as 5-HT(7) and 5-HT(1A) receptor ligands.
Salerno L; Pittalà V; Modica MN; Siracusa MA; Intagliata S; Cagnotto A; Salmona M; Kurczab R; Bojarski AJ; Romeo G
Eur J Med Chem; 2014 Oct; 85():716-26. PubMed ID: 25128671
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.
Pettersson M; Campbell BM; Dounay AB; Gray DL; Xie L; O'Donnell CJ; Stratman NC; Zoski K; Drummond E; Bora G; Probert A; Whisman T
Bioorg Med Chem Lett; 2011 Jan; 21(2):865-8. PubMed ID: 21185183
[TBL] [Abstract][Full Text] [Related]
29. Allosteric modulation of 5-HT(1A) receptors by zinc: Binding studies.
Barrondo S; Sallés J
Neuropharmacology; 2009 Feb; 56(2):455-62. PubMed ID: 18951909
[TBL] [Abstract][Full Text] [Related]
30. A new class of arylpiperazine derivatives: the library synthesis on SynPhase lanterns and biological evaluation on serotonin 5-HT(1A) and 5-HT(2A) receptors.
Zajdel P; Subra G; Bojarski AJ; Duszyńska B; Pawłowski M; Martinez J
J Comb Chem; 2004; 6(5):761-7. PubMed ID: 15360211
[TBL] [Abstract][Full Text] [Related]
31. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D
J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407
[TBL] [Abstract][Full Text] [Related]
32. Higher-Affinity Agonists of 5-HT1AR Discovered through Tuning the Binding-Site Flexibility.
Lian P; Li L; Geng C; Zhen X; Fu W
J Chem Inf Model; 2015 Aug; 55(8):1616-27. PubMed ID: 26131601
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, biological evaluation and molecular modeling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT
Franchini S; Manasieva LI; Sorbi C; Battisti UM; Fossa P; Cichero E; Denora N; Iacobazzi RM; Cilia A; Pirona L; Ronsisvalle S; Aricò G; Brasili L
Eur J Med Chem; 2017 Jan; 125():435-452. PubMed ID: 27689727
[TBL] [Abstract][Full Text] [Related]
34. 1,3-Dioxolane-based ligands as rigid analogues of naftopidil: structure-affinity/activity relationships at alpha1 and 5-HT1A receptors.
Sorbi C; Franchini S; Tait A; Prandi A; Gallesi R; Angeli P; Marucci G; Pirona L; Poggesi E; Brasili L
ChemMedChem; 2009 Mar; 4(3):393-9. PubMed ID: 19152363
[TBL] [Abstract][Full Text] [Related]
35. Bivalent ligand approach on 4-[2-(3-methoxyphenyl)ethyl]-1-(2-methoxyphenyl)piperazine: synthesis and binding affinities for 5-HT(7) and 5-HT(1A) receptors.
Leopoldo M; Lacivita E; Colabufo NA; Niso M; Berardi F; Perrone R
Bioorg Med Chem; 2007 Aug; 15(15):5316-21. PubMed ID: 17517509
[TBL] [Abstract][Full Text] [Related]
36. Development of heterocyclic-based frameworks as potential scaffold of 5-HT1A receptor agonist and future perspectives: A review.
Yuan W; Ma Y; Zhang H
Medicine (Baltimore); 2024 Jun; 103(24):e38496. PubMed ID: 38875413
[TBL] [Abstract][Full Text] [Related]
37. Molecular docking, dynamics simulations and 3D-QSAR modeling of arylpiperazine derivatives of 3,5-dioxo-(2H,4H)-1,2,4-triazine as 5-HT
Sherin DR; Geethu CK; Prabhakaran J; Mann JJ; Dileep Kumar JS; Manojkumar TK
Comput Biol Chem; 2019 Feb; 78():108-115. PubMed ID: 30502727
[TBL] [Abstract][Full Text] [Related]
38. Intrinsic activity and comparative molecular dynamics of buspirone analogues at the 5-HT(1A) receptors.
Strzelczyk AA; Jarończyk M; Chilmonczyk Z; Mazurek AP; Chojnacka-Wójcik E; Sylte I
Biochem Pharmacol; 2004 Jun; 67(12):2219-30. PubMed ID: 15163553
[TBL] [Abstract][Full Text] [Related]
39. Functional Selectivity and Antidepressant Activity of Serotonin 1A Receptor Ligands.
Chilmonczyk Z; Bojarski AJ; Pilc A; Sylte I
Int J Mol Sci; 2015 Aug; 16(8):18474-506. PubMed ID: 26262615
[TBL] [Abstract][Full Text] [Related]
40. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.
Cappelli A; Anzini M; Vomero S; Mennuni L; Makovec F; Doucet E; Hamon M; Bruni G; Romeo MR; Menziani MC; De Benedetti PG; Langer T
J Med Chem; 1998 Feb; 41(5):728-41. PubMed ID: 9513601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
